NEW YORK, May 16, 2023 /PRNewswire/ — The Klein Law Firm announces that it is investigating allegations that Relmada Therapeutics, Inc. (“Relmada” or the “Company”) (NYSE: RLMD) violated federal securities laws. CURRENT INVESTIGATION DETAILS: Before market opened on October 13, 2022, Relmada announced the results of its RELIANCE III study…Read More
RLMD NEWS The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Relmada Therapeutics Inc MarketScreener
